
As we move into 2024, the Life Sciences sector in Europe and the UK continues to face a dynamic and challenging regulatory environment. The EU Medical Device Regulation (MDR), effective since May 26, 2021, and the ongoing impacts of Brexit, the United Kingdom’s 2020 exit from the European Union, remain central issues. These changes are […]
